Pharma
Eli Lilly, Novo Nordisk report strong earnings as GLP-1 race heats up
Both drugmakers saw strong YoY sales, though Novo’s GLP-1 sales were down slightly from Q4 2024.
Both drugmakers saw strong YoY sales, though Novo’s GLP-1 sales were down slightly from Q4 2024.
It was a busy Q1 for the retail pharmacy giant.
Because who doesn’t prefer swallowing a pill over getting a shot?
The telehealth provider has sold compounded versions of Novo’s GLP-1 since 2022.
Insurers have warned the proposed requirement would be costly.
In a $350m deal, AbbVie bought a Danish weight loss drug in Phase 1 clinical trials.
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.